Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Roche Norge AS
AS
Active
Org 935925525
Brynsengfaret 6B, 0667
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1984 · 41 years old
47 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Roche Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
880M
660M
440M
220M
0M
2020: 547M
547M
2020
2021: 511M (-7% vs 2020)
511M
-7%
2021
2022: 535M (+5% vs 2021)
535M
+5%
2022
2023: 582M (+9% vs 2022)
582M
+9%
2023
2024: 707M (+21% vs 2023)
707M
+21%
2024
EBITDA
NOK millions
31M
23M
16M
8M
0M
2020: 25M
25M
2020
2021: 20M (-20% vs 2020)
20M
-20%
2021
2022: 11M (-45% vs 2021)
11M
-45%
2022
2023: 20M (+82% vs 2022)
20M
+82%
2023
2024: 24M (+20% vs 2023)
24M
+20%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
706 693
582 155
535 240
510 921
547 313
Staff expenses
−83 470
−79 482
−85 804
−86 854
−94 363
EBITDA
23 895
19 951
10 746
20 121
25 067
Depreciation & amort.
−282
−303
−312
−315
−670
EBIT
23 613
19 648
10 434
19 806
24 397
Net financials
−922
−1 405
−1 063
−114
−682
Profit before tax
22 691
18 243
9 371
19 692
23 715
Tax
5 236
4 181
2 189
4 338
5 529
Net profit
17 455
14 062
7 182
15 354
18 186
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
247 333
247 544
192 721
199 105
215 615
Equity
90 495
72 767
58 705
51 530
36 176
Long-term debt
0
0
0
0
0
Short-term debt
156 838
174 777
134 016
147 575
179 437
Total debt
156 838
174 777
134 016
147 575
179 437
Financial ratios
5-year trend
EBITDA margin
3,4 %
This company
15,8 %
Market median
This company
Market median
78% below market
2020
2024
Equity ratio
36,6 %
This company
38,2 %
Market median
This company
Market median
4% below market
2020
2024
Return on equity
19,3 %
This company
18,4 %
Market median
This company
Market median
5% above market
2020
2024
Net profit margin
2,5 %
This company
8,1 %
Market median
This company
Market median
69% below market
2020
2024
Asset turnover
2,86×
This company
1,12×
Market median
This company
Market median
155% above market
2020
2024
Debt / equity
1,73×
This company
0,62×
Market median
This company
Market median
179% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Roche Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
